SlideShare a Scribd company logo
Uremia and Endothelial Cells
Pr S. Burtey
Centre de néphrologie et transplantation rénale
Vascular Resarch Center Marseille
Marseille
Confluence of interest
• Otsuka
• Amgen
• Fresenius
• Gambro
• Alexion
• I’m nephrologist
• I lead a team working on uremic toxins and endothelial
cells
JAMA. 2015;314(17):1791-1792
“Fear is the enemy of logic.”
Endothelium
• A tissu, in fact numerous tissues
• Surface: 3000 to 6000 m2
• Thickness: 2 µm
• Weight: 720 g (600 g of capillaries)
• Each organ has its endothelium
• Transcriptome
• Patterns of Receptors
• Ability to react to an agression
• Artery Vs Vein Vs capillary
Physiological Reviews Vol. 89 no. 4, 1269-1339
Endothelial Functions
Endothelial Cell
Metabolism
Angiogenesis
Vascular
permeability
Vascular tone
Control of vSMC
proliferation
NO
H2S
PGI2
Endothelin
TXA2
PGH2
Hemostasis
TM
Glycocalyx
T-PA
TFPI
PGI2
vWF
TF
TXA2
PAI-1
Inflammation
Leucocytes
traffic
ICAM1, VCAM, E-Selectin, MCP1
Endothelial dysfunction
• A defect of endothelium to produce NO.
• Evaluation:
• Flow-mediated vasodilatation et Tonometry (Tousoulis et al. Pharmacology
& Therapeutics 144 (2014) 253–267)
• Biomarkers (Walczak et al. Pharmacological Reports 67 (2015) 771–777)
Furchgott, Nobel 1998
Healthy Endothelium
Vasodilatator (NO,H2S, PGI2)
Minimal oxydative stress
Anticoagulant (t-Pa, TFPI, Glycocalyx)
Anti-inflammatory
Balance lesion-regeneration in favor of
regeneration
Unhealthy Endothelium
Defect in Vasodilatation
Increased oxydative stress
Procoagulant (vWF, Tissue Factor, PAI-1)
Pro-inflammatory (ICAM,VCAM, E-
Selectin, MCP-1, IL6, TNF)
Reduced regeneration potentienal (reduced
number of progenitors, Increase in eMP )
Lost of glycocalyx (endocan)
Hyperglycemia Blood Pressure
Turbulent flow
Ox-LDL
Inflammation
Tobacco
ROS
AGEs
Obesity
Aging
Clinical impact of endothelial
dysfunction
World J Cardiol 2014; 6(8): 824-835
Why nephrologist must be aware of
endothelium ?
Is the endothelium dysfunctionnal
during CKD?
• Yes and at each stage.
Hirata et al. International Journal of Cardiology
173 (2014) 481–486
eGFR: 50 ml/mn
Chen et al. PLoS ONE 2015 10(7): e0132047
eGFR: 43 ml/mn
Jourde-Chiche et al. Seminars in dialysis 2011 p327–337
Recio-Mayoral et al. / Atherosclerosis 216 (2011) 446–451
Verbeke et al. Clin J Am Soc Nephrol 6: 2009–2015, 2011
Unhealthy endothelium and AVF
Hemodialysis Fistula Maturation Study Group
Resistance to NO
Endothelial dysfunction during CKD
Uremic Toxins
Healthy Endothelium
Vasodilatator (NO,H2S, PGI2)
Minimal oxydative stress
Anticoagulant (t-Pa, TFPI, Glycocalyx)
Anti-inflammatory
Balance lesion-regeneration in favor of
regeneration
Malfunctionning Endothelium
Defect in Vasodilatation
Increased oxydative stress
Procoagulant (vWF, Tissue Factor, PAI-1)
Pro-inflammatory (ICAM,VCAM, E-
Selectin, MCP-1, IL6, TNF)
Reduced regeneration potentienal (reduced
number of progenitors, Increase in eMP )
Lost of glycocalyx (endocan)
Hyperglycemia Blood Pressure
Turbulent flow
Ox-LDL
Inflammation
Tobacco
ROS
AGEs
Obesity
Aging
One of the strongest proof is given by
the kidney donor.
Rossi et al. Transplantation 2014;97: 548Y554)
Uremic Toxins
• Glomerular flow rate decline is associated with retention
of solutes:
• Negative interactions with biological functions
• Association with clinical events
• Three families
• Free water-soluble low molecular mass compounds (<0.5 kD)
• Middle molecules
• Protein-bound solutes
http://uremic-toxins.org/
131313
Phosphore
AGEs
HDL
Free water-soluble LMW molecules Protein-bound solutesMiddle molecules
ADMA and SDMA
HDL cholesterol
 Endothelial cell elixir of youth  In CKD, pure evil
Speer et al. Nephrol Dial Transplant (2013) 28: 2456–2463
AGEs
 Increase oxydative stress
 Reduced expression of eNOS
 Lower production of NO
 Reduced endothelial progenitors
 Reduced PGI2
 Increase ET-1
Stinghen et al. JASN 2015
Phosphate
Gross et al. Circulation Journal Vol. 78 (2014) p. 2339-2346
FMD
Stevens et al. Lancet. 2015 Feb 26;385 Suppl 1:S10 Silswal et al. Am J Physiol Endocrinol Metab 307: E426–E436, 2014
And FGF-23?
Para-cresyl sulfate
• Endothelial toxicity is mainly
mediated by leucocytes.
• On HUVECs, PCS increase the
production of ROS (Gross et al. J. Cell. Physiol. 230: 2927–
2935, 2015).
• Increase of ROS is secondary to
NOX activation.
Indoles
 Clinical effects  Biological Effects
 Reduced proliferation of
endothelial cells
 Increased production of ROS
 Increased production of
endothelial microparticules
 Reduced production of NO
 Increased interactions betwen
leucocytes and EC.
 Loss of glycocalyx
 Reduced number of EPC and
impaired neovascularisation
 Senescence
Dou, Sallée et al , Jasn 2015
IAAIS
Barreto et al, cJasn 2009
MortalityCVEvents
Vanholder et al, JASN 2014
Indoles
Vanholder et al, JASN 2014
Indoles
• What happened if we reduce the concentration of IS?
Six et al. Atherosclerosis 243 (2015) 248e256Yu et al. Clin J Am Soc Nephrol 6: 30–39, 2011
Indoles and Aryl Hydrocarbon Receptor
IS
IAA
Atherothrombosis
JASN April 2015 vol. 26 no. 4 876-887
AhR
F3,PTGS2
CYP1A1,CYP1A2
TF
COX2
P38
MAPK
NF-KB
NF-KB
Inflammation
Coagulation
Endothelial Cell
Indoles and endothelial progenitors
The Moirai and endothelium
 Klotho protects endothelium  As Atropos, indoxyl sulfate
How to restore healthy endothelium?
• Reducing the amount of uremic toxins
• Production
• Purification
• Statins
• Inh of ROS ?
• Soluble Klotho?
• Inh of AhR ?
Zafeiropoulou K. PLoS ONE 7(2): e30975
How to restore healthy endothelium?
Cocoa Flavanols
Conclusion
• Endothelium is activated during CKD.
• It plays a role in the increased CV of patients with CKD.
• Uremic toxins induce directly or indirectly activation of
endothelium.
• Activation of AhR during CKD activates endothelium
• Procoagulant
• Inflammatory.
• Chocolate is perhaps the future cure of unhealthy
endothelium during CKD.
An introduction to the talk of Griet
Glorieux

More Related Content

What's hot

Bone marrow transplantation
Bone marrow transplantationBone marrow transplantation
Bone marrow transplantation
suchitkumar24
 
Chronic allograft nephropathy
Chronic allograft nephropathyChronic allograft nephropathy
Chronic allograft nephropathy
nephropdt
 
ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...
Maarten Naesens
 
BONE MARROW TRANSPLANT
BONE MARROW TRANSPLANTBONE MARROW TRANSPLANT
BONE MARROW TRANSPLANT
SUDESHNA BANERJEE
 
Cellular Immune Therapy with Allogeneic Stem Cell Transplantation
Cellular Immune Therapy with Allogeneic Stem Cell TransplantationCellular Immune Therapy with Allogeneic Stem Cell Transplantation
Cellular Immune Therapy with Allogeneic Stem Cell Transplantation
spa718
 
Acute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 ChakenAcute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 Chaken
CHAKEN MANIYAN
 
Kidney transplantation outcome complication chaken
Kidney transplantation outcome complication chakenKidney transplantation outcome complication chaken
Kidney transplantation outcome complication chaken
CHAKEN MANIYAN
 
Stem cell transplantation
Stem cell transplantationStem cell transplantation
Stem cell transplantation
Shilpa Reddy
 
Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...
Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...
Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...
Society of International Business Fellows
 
Presentatie Prof. dr. Doevendans en Prof. dr. Clevers
Presentatie Prof. dr. Doevendans en Prof. dr. CleversPresentatie Prof. dr. Doevendans en Prof. dr. Clevers
Presentatie Prof. dr. Doevendans en Prof. dr. Clevers
CVON
 
ไวน์แดงกับหลอดเลือด
ไวน์แดงกับหลอดเลือดไวน์แดงกับหลอดเลือด
ไวน์แดงกับหลอดเลือด
สปสช นครสวรรค์
 
Immunosupuression in adult liver transplantation
Immunosupuression in adult liver transplantation Immunosupuression in adult liver transplantation
Immunosupuression in adult liver transplantation
Abhishek Yadav
 
Topic scleroderma and kidney Chaken Maniyan
Topic scleroderma and kidney Chaken ManiyanTopic scleroderma and kidney Chaken Maniyan
Topic scleroderma and kidney Chaken Maniyan
CHAKEN MANIYAN
 
Dr kamlesh patel bone marrow transplantation
Dr kamlesh patel   bone marrow transplantationDr kamlesh patel   bone marrow transplantation
Dr kamlesh patel bone marrow transplantation
www.jaailab.com
 
Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...
Scleroderma & Raynaud's UK (SRUK)
 
Vp watch editorial - v2 n2- 2002
Vp watch   editorial - v2 n2- 2002Vp watch   editorial - v2 n2- 2002
Vp watch editorial - v2 n2- 2002
Society for Heart Attack Prevention and Eradication
 
Deceased donor kidney transplantation-Recipient care.
Deceased donor kidney transplantation-Recipient care.Deceased donor kidney transplantation-Recipient care.
Deceased donor kidney transplantation-Recipient care.
Vishal Golay
 
225 animal models of heart attack part 2
225 animal models of heart attack part 2225 animal models of heart attack part 2
225 animal models of heart attack part 2
Society for Heart Attack Prevention and Eradication
 
HEMATOPOIETIC STEM CELL TRANSPLANTS IN PEDIATRIC by DR ABHIJEET MANOHAR WANKHEDE
HEMATOPOIETIC STEM CELL TRANSPLANTS IN PEDIATRIC by DR ABHIJEET MANOHAR WANKHEDEHEMATOPOIETIC STEM CELL TRANSPLANTS IN PEDIATRIC by DR ABHIJEET MANOHAR WANKHEDE
HEMATOPOIETIC STEM CELL TRANSPLANTS IN PEDIATRIC by DR ABHIJEET MANOHAR WANKHEDE
Abhijeet Wankhede
 
Vp watch2002
Vp watch2002Vp watch2002

What's hot (20)

Bone marrow transplantation
Bone marrow transplantationBone marrow transplantation
Bone marrow transplantation
 
Chronic allograft nephropathy
Chronic allograft nephropathyChronic allograft nephropathy
Chronic allograft nephropathy
 
ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...
 
BONE MARROW TRANSPLANT
BONE MARROW TRANSPLANTBONE MARROW TRANSPLANT
BONE MARROW TRANSPLANT
 
Cellular Immune Therapy with Allogeneic Stem Cell Transplantation
Cellular Immune Therapy with Allogeneic Stem Cell TransplantationCellular Immune Therapy with Allogeneic Stem Cell Transplantation
Cellular Immune Therapy with Allogeneic Stem Cell Transplantation
 
Acute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 ChakenAcute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 Chaken
 
Kidney transplantation outcome complication chaken
Kidney transplantation outcome complication chakenKidney transplantation outcome complication chaken
Kidney transplantation outcome complication chaken
 
Stem cell transplantation
Stem cell transplantationStem cell transplantation
Stem cell transplantation
 
Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...
Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...
Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...
 
Presentatie Prof. dr. Doevendans en Prof. dr. Clevers
Presentatie Prof. dr. Doevendans en Prof. dr. CleversPresentatie Prof. dr. Doevendans en Prof. dr. Clevers
Presentatie Prof. dr. Doevendans en Prof. dr. Clevers
 
ไวน์แดงกับหลอดเลือด
ไวน์แดงกับหลอดเลือดไวน์แดงกับหลอดเลือด
ไวน์แดงกับหลอดเลือด
 
Immunosupuression in adult liver transplantation
Immunosupuression in adult liver transplantation Immunosupuression in adult liver transplantation
Immunosupuression in adult liver transplantation
 
Topic scleroderma and kidney Chaken Maniyan
Topic scleroderma and kidney Chaken ManiyanTopic scleroderma and kidney Chaken Maniyan
Topic scleroderma and kidney Chaken Maniyan
 
Dr kamlesh patel bone marrow transplantation
Dr kamlesh patel   bone marrow transplantationDr kamlesh patel   bone marrow transplantation
Dr kamlesh patel bone marrow transplantation
 
Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...
 
Vp watch editorial - v2 n2- 2002
Vp watch   editorial - v2 n2- 2002Vp watch   editorial - v2 n2- 2002
Vp watch editorial - v2 n2- 2002
 
Deceased donor kidney transplantation-Recipient care.
Deceased donor kidney transplantation-Recipient care.Deceased donor kidney transplantation-Recipient care.
Deceased donor kidney transplantation-Recipient care.
 
225 animal models of heart attack part 2
225 animal models of heart attack part 2225 animal models of heart attack part 2
225 animal models of heart attack part 2
 
HEMATOPOIETIC STEM CELL TRANSPLANTS IN PEDIATRIC by DR ABHIJEET MANOHAR WANKHEDE
HEMATOPOIETIC STEM CELL TRANSPLANTS IN PEDIATRIC by DR ABHIJEET MANOHAR WANKHEDEHEMATOPOIETIC STEM CELL TRANSPLANTS IN PEDIATRIC by DR ABHIJEET MANOHAR WANKHEDE
HEMATOPOIETIC STEM CELL TRANSPLANTS IN PEDIATRIC by DR ABHIJEET MANOHAR WANKHEDE
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 

Viewers also liked

Physiopathologie et perspectives thérapeutiques dans la polykystose rénale
Physiopathologie et perspectives thérapeutiques dans la polykystose rénalePhysiopathologie et perspectives thérapeutiques dans la polykystose rénale
Physiopathologie et perspectives thérapeutiques dans la polykystose rénale
kyste
 
MedicalValley Talks am 14.04.2011 mit Prof. Fabry
MedicalValley Talks am 14.04.2011 mit Prof. FabryMedicalValley Talks am 14.04.2011 mit Prof. Fabry
MedicalValley Talks am 14.04.2011 mit Prof. Fabry
Medical Valley EMN
 
Hungary2002
Hungary2002Hungary2002
Presentation format4 posttranslational modification in cell adhesion and migr...
Presentation format4 posttranslational modification in cell adhesion and migr...Presentation format4 posttranslational modification in cell adhesion and migr...
Presentation format4 posttranslational modification in cell adhesion and migr...
Birgit Kastberger
 
Leukocyte Trafficking in Health and Diseases 2016
Leukocyte Trafficking in Health and Diseases 2016Leukocyte Trafficking in Health and Diseases 2016
Leukocyte Trafficking in Health and Diseases 2016
BostonIDI
 
İng tip adezyonmoleküll
İng tip adezyonmoleküllİng tip adezyonmoleküll
İng tip adezyonmoleküll
DrAlirza
 
L02 cell membrane_
L02 cell membrane_L02 cell membrane_
L02 cell membrane_
MUBOSScz
 
Lymphocyte Migration
Lymphocyte MigrationLymphocyte Migration
Lymphocyte Migration
raj kumar
 
adhesion_proteins
adhesion_proteinsadhesion_proteins
adhesion_proteins
himakiran_babu
 
Adhesion molecules in skin seminar (2)
Adhesion molecules in skin  seminar (2)Adhesion molecules in skin  seminar (2)
Adhesion molecules in skin seminar (2)
Dr Daulatram Dhaked
 
Morphogenesis and cell adhesion.
Morphogenesis and cell adhesion.Morphogenesis and cell adhesion.
Morphogenesis and cell adhesion.
Bhupen Koch
 
Cell Adhesion and Cell Migration
Cell Adhesion and Cell MigrationCell Adhesion and Cell Migration
Cell Adhesion and Cell Migration
Antonia Jameson Jordan
 
Cellular Adhesion in Inflammation
Cellular Adhesion in InflammationCellular Adhesion in Inflammation
Neutrophils
NeutrophilsNeutrophils
Adhesion molecules
Adhesion moleculesAdhesion molecules
Adhesion molecules
aljeirou
 
2. inflammation cellular events dr ashutosh kumar
2. inflammation cellular events dr ashutosh kumar2. inflammation cellular events dr ashutosh kumar
2. inflammation cellular events dr ashutosh kumar
DrAshutosh Kumar
 
Cell adhesion molecules and matrix proteins
Cell adhesion    molecules and matrix proteinsCell adhesion    molecules and matrix proteins
Cell adhesion molecules and matrix proteins
USmile Ï Ṩṃïlệ
 
Vesiculobullous Diseases
Vesiculobullous DiseasesVesiculobullous Diseases
Vesiculobullous Diseases
Ibrahim Farag
 
Lee Mangiante Masters Thesis
Lee Mangiante Masters ThesisLee Mangiante Masters Thesis
Lee Mangiante Masters Thesis
leemangiante
 
Masters Defense
Masters DefenseMasters Defense
Masters Defense
leemangiante
 

Viewers also liked (20)

Physiopathologie et perspectives thérapeutiques dans la polykystose rénale
Physiopathologie et perspectives thérapeutiques dans la polykystose rénalePhysiopathologie et perspectives thérapeutiques dans la polykystose rénale
Physiopathologie et perspectives thérapeutiques dans la polykystose rénale
 
MedicalValley Talks am 14.04.2011 mit Prof. Fabry
MedicalValley Talks am 14.04.2011 mit Prof. FabryMedicalValley Talks am 14.04.2011 mit Prof. Fabry
MedicalValley Talks am 14.04.2011 mit Prof. Fabry
 
Hungary2002
Hungary2002Hungary2002
Hungary2002
 
Presentation format4 posttranslational modification in cell adhesion and migr...
Presentation format4 posttranslational modification in cell adhesion and migr...Presentation format4 posttranslational modification in cell adhesion and migr...
Presentation format4 posttranslational modification in cell adhesion and migr...
 
Leukocyte Trafficking in Health and Diseases 2016
Leukocyte Trafficking in Health and Diseases 2016Leukocyte Trafficking in Health and Diseases 2016
Leukocyte Trafficking in Health and Diseases 2016
 
İng tip adezyonmoleküll
İng tip adezyonmoleküllİng tip adezyonmoleküll
İng tip adezyonmoleküll
 
L02 cell membrane_
L02 cell membrane_L02 cell membrane_
L02 cell membrane_
 
Lymphocyte Migration
Lymphocyte MigrationLymphocyte Migration
Lymphocyte Migration
 
adhesion_proteins
adhesion_proteinsadhesion_proteins
adhesion_proteins
 
Adhesion molecules in skin seminar (2)
Adhesion molecules in skin  seminar (2)Adhesion molecules in skin  seminar (2)
Adhesion molecules in skin seminar (2)
 
Morphogenesis and cell adhesion.
Morphogenesis and cell adhesion.Morphogenesis and cell adhesion.
Morphogenesis and cell adhesion.
 
Cell Adhesion and Cell Migration
Cell Adhesion and Cell MigrationCell Adhesion and Cell Migration
Cell Adhesion and Cell Migration
 
Cellular Adhesion in Inflammation
Cellular Adhesion in InflammationCellular Adhesion in Inflammation
Cellular Adhesion in Inflammation
 
Neutrophils
NeutrophilsNeutrophils
Neutrophils
 
Adhesion molecules
Adhesion moleculesAdhesion molecules
Adhesion molecules
 
2. inflammation cellular events dr ashutosh kumar
2. inflammation cellular events dr ashutosh kumar2. inflammation cellular events dr ashutosh kumar
2. inflammation cellular events dr ashutosh kumar
 
Cell adhesion molecules and matrix proteins
Cell adhesion    molecules and matrix proteinsCell adhesion    molecules and matrix proteins
Cell adhesion molecules and matrix proteins
 
Vesiculobullous Diseases
Vesiculobullous DiseasesVesiculobullous Diseases
Vesiculobullous Diseases
 
Lee Mangiante Masters Thesis
Lee Mangiante Masters ThesisLee Mangiante Masters Thesis
Lee Mangiante Masters Thesis
 
Masters Defense
Masters DefenseMasters Defense
Masters Defense
 

Similar to Uremia and endothelial cells

The Vascular Endothelium, Nutrients, and Diseases
The Vascular Endothelium, Nutrients, and DiseasesThe Vascular Endothelium, Nutrients, and Diseases
The Vascular Endothelium, Nutrients, and Diseases
Suthipong Pongworn
 
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse ModelVascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
Scintica Instrumentation
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
OsteoarthritisOsteoarthritis
Dr Q's Nitro Max
Dr Q's Nitro MaxDr Q's Nitro Max
Dr Q's Nitro Max
William Kane
 
Am J Physiol Regul Integr Comp Physiol-2012-Evanson-R651-7
Am J Physiol Regul Integr Comp Physiol-2012-Evanson-R651-7Am J Physiol Regul Integr Comp Physiol-2012-Evanson-R651-7
Am J Physiol Regul Integr Comp Physiol-2012-Evanson-R651-7
Enoch Samraj, PT DPT CSCS
 
Yousry Endothelial Vs Erectile Dysfunction
Yousry Endothelial Vs Erectile DysfunctionYousry Endothelial Vs Erectile Dysfunction
Yousry Endothelial Vs Erectile Dysfunction
guest5a246c
 
Dr Q Vitamins - NitroMax
Dr Q Vitamins - NitroMaxDr Q Vitamins - NitroMax
Dr Q Vitamins - NitroMax
William Kane
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
fathi neana
 
Motor_neuron_disease.ppt
Motor_neuron_disease.pptMotor_neuron_disease.ppt
Motor_neuron_disease.ppt
DrSachinPandey2
 
sodapdf-converted.pptx
sodapdf-converted.pptxsodapdf-converted.pptx
sodapdf-converted.pptx
EllyanaFarina1
 
Resveratrol - Improve Cellular & Heart Health
Resveratrol - Improve Cellular & Heart HealthResveratrol - Improve Cellular & Heart Health
Resveratrol - Improve Cellular & Heart Health
Michael J. Daras
 
1120908-自體幹細胞治療退化性關節炎.pdf
1120908-自體幹細胞治療退化性關節炎.pdf1120908-自體幹細胞治療退化性關節炎.pdf
1120908-自體幹細胞治療退化性關節炎.pdf
Ks doctor
 
Disc regeneration
Disc regenerationDisc regeneration
Disc regeneration
Babak Ashrafnejad MD
 
20160113 after the biologics where will you be
20160113 after the biologics where will you be20160113 after the biologics where will you be
20160113 after the biologics where will you be
Kailen Tsai
 
Thesis Defense
Thesis DefenseThesis Defense
Thesis Defense
warrenyates
 
Alperi̇skiti̇
Alperi̇skiti̇Alperi̇skiti̇
Alperi̇skiti̇
tyfngnc
 
Angiogenesis in health and disease
Angiogenesis in health and diseaseAngiogenesis in health and disease
Angiogenesis in health and disease
Dibyajyoti Prusty
 
Future Inoroivement in Cardiac Regenerative Medicine
Future Inoroivement in Cardiac Regenerative MedicineFuture Inoroivement in Cardiac Regenerative Medicine
Future Inoroivement in Cardiac Regenerative Medicine
Budi Pikir
 

Similar to Uremia and endothelial cells (20)

The Vascular Endothelium, Nutrients, and Diseases
The Vascular Endothelium, Nutrients, and DiseasesThe Vascular Endothelium, Nutrients, and Diseases
The Vascular Endothelium, Nutrients, and Diseases
 
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse ModelVascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Dr Q's Nitro Max
Dr Q's Nitro MaxDr Q's Nitro Max
Dr Q's Nitro Max
 
Am J Physiol Regul Integr Comp Physiol-2012-Evanson-R651-7
Am J Physiol Regul Integr Comp Physiol-2012-Evanson-R651-7Am J Physiol Regul Integr Comp Physiol-2012-Evanson-R651-7
Am J Physiol Regul Integr Comp Physiol-2012-Evanson-R651-7
 
Yousry Endothelial Vs Erectile Dysfunction
Yousry Endothelial Vs Erectile DysfunctionYousry Endothelial Vs Erectile Dysfunction
Yousry Endothelial Vs Erectile Dysfunction
 
Dr Q Vitamins - NitroMax
Dr Q Vitamins - NitroMaxDr Q Vitamins - NitroMax
Dr Q Vitamins - NitroMax
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Motor_neuron_disease.ppt
Motor_neuron_disease.pptMotor_neuron_disease.ppt
Motor_neuron_disease.ppt
 
sodapdf-converted.pptx
sodapdf-converted.pptxsodapdf-converted.pptx
sodapdf-converted.pptx
 
Resveratrol - Improve Cellular & Heart Health
Resveratrol - Improve Cellular & Heart HealthResveratrol - Improve Cellular & Heart Health
Resveratrol - Improve Cellular & Heart Health
 
1120908-自體幹細胞治療退化性關節炎.pdf
1120908-自體幹細胞治療退化性關節炎.pdf1120908-自體幹細胞治療退化性關節炎.pdf
1120908-自體幹細胞治療退化性關節炎.pdf
 
Disc regeneration
Disc regenerationDisc regeneration
Disc regeneration
 
20160113 after the biologics where will you be
20160113 after the biologics where will you be20160113 after the biologics where will you be
20160113 after the biologics where will you be
 
Thesis Defense
Thesis DefenseThesis Defense
Thesis Defense
 
Alperi̇skiti̇
Alperi̇skiti̇Alperi̇skiti̇
Alperi̇skiti̇
 
Angiogenesis in health and disease
Angiogenesis in health and diseaseAngiogenesis in health and disease
Angiogenesis in health and disease
 
Future Inoroivement in Cardiac Regenerative Medicine
Future Inoroivement in Cardiac Regenerative MedicineFuture Inoroivement in Cardiac Regenerative Medicine
Future Inoroivement in Cardiac Regenerative Medicine
 

Recently uploaded

NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
rightmanforbloodline
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
AyushGadhvi1
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 

Recently uploaded (20)

NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 

Uremia and endothelial cells

  • 1. Uremia and Endothelial Cells Pr S. Burtey Centre de néphrologie et transplantation rénale Vascular Resarch Center Marseille Marseille
  • 2. Confluence of interest • Otsuka • Amgen • Fresenius • Gambro • Alexion • I’m nephrologist • I lead a team working on uremic toxins and endothelial cells JAMA. 2015;314(17):1791-1792 “Fear is the enemy of logic.”
  • 3. Endothelium • A tissu, in fact numerous tissues • Surface: 3000 to 6000 m2 • Thickness: 2 µm • Weight: 720 g (600 g of capillaries) • Each organ has its endothelium • Transcriptome • Patterns of Receptors • Ability to react to an agression • Artery Vs Vein Vs capillary Physiological Reviews Vol. 89 no. 4, 1269-1339
  • 4. Endothelial Functions Endothelial Cell Metabolism Angiogenesis Vascular permeability Vascular tone Control of vSMC proliferation NO H2S PGI2 Endothelin TXA2 PGH2 Hemostasis TM Glycocalyx T-PA TFPI PGI2 vWF TF TXA2 PAI-1 Inflammation Leucocytes traffic ICAM1, VCAM, E-Selectin, MCP1
  • 5. Endothelial dysfunction • A defect of endothelium to produce NO. • Evaluation: • Flow-mediated vasodilatation et Tonometry (Tousoulis et al. Pharmacology & Therapeutics 144 (2014) 253–267) • Biomarkers (Walczak et al. Pharmacological Reports 67 (2015) 771–777) Furchgott, Nobel 1998 Healthy Endothelium Vasodilatator (NO,H2S, PGI2) Minimal oxydative stress Anticoagulant (t-Pa, TFPI, Glycocalyx) Anti-inflammatory Balance lesion-regeneration in favor of regeneration Unhealthy Endothelium Defect in Vasodilatation Increased oxydative stress Procoagulant (vWF, Tissue Factor, PAI-1) Pro-inflammatory (ICAM,VCAM, E- Selectin, MCP-1, IL6, TNF) Reduced regeneration potentienal (reduced number of progenitors, Increase in eMP ) Lost of glycocalyx (endocan) Hyperglycemia Blood Pressure Turbulent flow Ox-LDL Inflammation Tobacco ROS AGEs Obesity Aging
  • 6. Clinical impact of endothelial dysfunction World J Cardiol 2014; 6(8): 824-835
  • 7. Why nephrologist must be aware of endothelium ?
  • 8. Is the endothelium dysfunctionnal during CKD? • Yes and at each stage. Hirata et al. International Journal of Cardiology 173 (2014) 481–486 eGFR: 50 ml/mn Chen et al. PLoS ONE 2015 10(7): e0132047 eGFR: 43 ml/mn Jourde-Chiche et al. Seminars in dialysis 2011 p327–337 Recio-Mayoral et al. / Atherosclerosis 216 (2011) 446–451 Verbeke et al. Clin J Am Soc Nephrol 6: 2009–2015, 2011
  • 9. Unhealthy endothelium and AVF Hemodialysis Fistula Maturation Study Group Resistance to NO
  • 10. Endothelial dysfunction during CKD Uremic Toxins Healthy Endothelium Vasodilatator (NO,H2S, PGI2) Minimal oxydative stress Anticoagulant (t-Pa, TFPI, Glycocalyx) Anti-inflammatory Balance lesion-regeneration in favor of regeneration Malfunctionning Endothelium Defect in Vasodilatation Increased oxydative stress Procoagulant (vWF, Tissue Factor, PAI-1) Pro-inflammatory (ICAM,VCAM, E- Selectin, MCP-1, IL6, TNF) Reduced regeneration potentienal (reduced number of progenitors, Increase in eMP ) Lost of glycocalyx (endocan) Hyperglycemia Blood Pressure Turbulent flow Ox-LDL Inflammation Tobacco ROS AGEs Obesity Aging
  • 11. One of the strongest proof is given by the kidney donor. Rossi et al. Transplantation 2014;97: 548Y554)
  • 12. Uremic Toxins • Glomerular flow rate decline is associated with retention of solutes: • Negative interactions with biological functions • Association with clinical events • Three families • Free water-soluble low molecular mass compounds (<0.5 kD) • Middle molecules • Protein-bound solutes http://uremic-toxins.org/
  • 13. 131313 Phosphore AGEs HDL Free water-soluble LMW molecules Protein-bound solutesMiddle molecules
  • 15. HDL cholesterol  Endothelial cell elixir of youth  In CKD, pure evil Speer et al. Nephrol Dial Transplant (2013) 28: 2456–2463
  • 16. AGEs  Increase oxydative stress  Reduced expression of eNOS  Lower production of NO  Reduced endothelial progenitors  Reduced PGI2  Increase ET-1 Stinghen et al. JASN 2015
  • 17. Phosphate Gross et al. Circulation Journal Vol. 78 (2014) p. 2339-2346 FMD Stevens et al. Lancet. 2015 Feb 26;385 Suppl 1:S10 Silswal et al. Am J Physiol Endocrinol Metab 307: E426–E436, 2014 And FGF-23?
  • 18. Para-cresyl sulfate • Endothelial toxicity is mainly mediated by leucocytes. • On HUVECs, PCS increase the production of ROS (Gross et al. J. Cell. Physiol. 230: 2927– 2935, 2015). • Increase of ROS is secondary to NOX activation.
  • 19. Indoles  Clinical effects  Biological Effects  Reduced proliferation of endothelial cells  Increased production of ROS  Increased production of endothelial microparticules  Reduced production of NO  Increased interactions betwen leucocytes and EC.  Loss of glycocalyx  Reduced number of EPC and impaired neovascularisation  Senescence Dou, Sallée et al , Jasn 2015 IAAIS Barreto et al, cJasn 2009 MortalityCVEvents Vanholder et al, JASN 2014
  • 21. Indoles • What happened if we reduce the concentration of IS? Six et al. Atherosclerosis 243 (2015) 248e256Yu et al. Clin J Am Soc Nephrol 6: 30–39, 2011
  • 22. Indoles and Aryl Hydrocarbon Receptor IS IAA Atherothrombosis JASN April 2015 vol. 26 no. 4 876-887 AhR F3,PTGS2 CYP1A1,CYP1A2 TF COX2 P38 MAPK NF-KB NF-KB Inflammation Coagulation Endothelial Cell
  • 23. Indoles and endothelial progenitors
  • 24. The Moirai and endothelium  Klotho protects endothelium  As Atropos, indoxyl sulfate
  • 25. How to restore healthy endothelium? • Reducing the amount of uremic toxins • Production • Purification • Statins • Inh of ROS ? • Soluble Klotho? • Inh of AhR ? Zafeiropoulou K. PLoS ONE 7(2): e30975
  • 26. How to restore healthy endothelium? Cocoa Flavanols
  • 27. Conclusion • Endothelium is activated during CKD. • It plays a role in the increased CV of patients with CKD. • Uremic toxins induce directly or indirectly activation of endothelium. • Activation of AhR during CKD activates endothelium • Procoagulant • Inflammatory. • Chocolate is perhaps the future cure of unhealthy endothelium during CKD.
  • 28. An introduction to the talk of Griet Glorieux

Editor's Notes

  1. Ladies and gentlemen good morning, I thank the organizators to give the opportunity to talk about the impact of uremic toxins on endothelial cells
  2. First my confluenc of interest, i think the main one is that I have a group working on uremic toxins and EC.
  3. Endothelium is a real tissue, in fact numerous tissues as the number of organs or subregion in organ. As you know for exemple the glomerular endothelium is different from the peritubular. Endothelium is a large organe but thin organe, its thickness is the thikness of the monolayer of endothelial cell. Each organ have its endothelium with its transcriptomic landscape, its pattern of receptor and various properities. IN addition you could differentiate in each organ arteries, veins endothelium and capollary beds with various functions
  4. Endothelium controls the vascular tone mainly by the balance betwen nitrous oxyde ad endothelin. It control the vacular permeability and the proliferation of vascular smooth muscle cell. Endothelium plays important role in inflammation mainly by controlin the leucocytes traffic from blood to the tissues. One of its most important fonction is hemostatis. It could produce numerous protein involved in primary hemostasis, coagulation and fibrinolysis. Finally it plays a role in angiogenesis normal and pathologic and the metabolism of tissues via its permability.
  5. Endothelium could dysfunction, the main marker of it its inability to produce NO. In fact it could be better to talk of a transition from an healthy to an unhealthy endothelume. Healthy iis vasodilatation the unhealthy is defective, the healthy have a low level of oxydative stress, and it avoid formation of clots the unhealthy is clearly procoagulant and proinflamatory. And fiany the balance between lesion and regenration and lost of glycocalyx. Numerous causes could induce activation of endothelium frome physiological like aging to exposur to tobacco. You could evaluate the health of the endotheiluum by its ability to release NO and you study the flow mediated vasodilatation or you measure various biomarkers produce by unhealthy endothelium.
  6. In general population there is a large amount of studies showing a relation betwen endothelial dysfunction and cardiovascular risk.
  7. As you know CKD is associated with an increased cardiovascular risk. The traditionnal risk factor di not explain the overrisk. So major endothelial dysfunction could be a mediator of CV risk during CKD.
  8. The endothelium during CKD is unhealthy and associated with and increase risk of CV events. The level of dysfunction prodress with CKD and regress with successful kidney transplantation.
  9. IN addition it is also associated with the risk of dysfunctionnal arteriovenous fistula in human and rodents. As you can see. The severity of ED is associated with a reduced diameter and flow in the AVF interestingly the same results was observed in rat with CKD compared to control. SO endothelium could control the patency of vascular access.
  10. During CKD beside traditionnals aggresors of the endotelium one unique is present: the uremic toxins
  11. The best proof of the role of the uremic toxins could induced endothelial dysfunction is provide by this australian study. They measure two uremic toxin and endothelial function in kidney donor and they observed n increase of uremic toxins and an impaired endothelium function.
  12. Uremic toxins are solute accumulationg with the GFR loss. A uremic toxins induce impairment of biological process and/or is associated with clinical events. 3 families of uremce toxins
  13. I choosed to talk of toxins with a well documented effects on EC. I will not talf of Il6, TNF a,d homocysteine they could be endtheliotoxine
  14. ADMA and SDMA accumulate during CKD and induced endothelial dysfunction mainly by inhibition of NOS. They are clearly associated with an increase of CV risk.
  15. HDL cholesterol is the endothelium elixir of youth, it improves all the parameter antiinflamatory, limitation of ROS, but in CKD it is pure evil inducing endothelial dysfunction by various phenomenom. Interestingly recently gene variant inducing raise in HDL is also associated with heart diseases.
  16. Ages accumulation during CKD is also associated with endothelial dysfunction by increasing oxydative stress ther reduced enos activity, dmminished the number of endothelial progenitor ena indced expression of endothelin 1
  17. Phosphate induced endothelial dusfunction with diminshed production of nos in ducing a limited FMS in patient, apoptosis of EC. FGF 23could also directly limited the production of NO.
  18. For a long time, we think that endothelial toxicity of PCS was secondary to leucocytes. Two recent papers show us that PCS could induced and increase ROS production directly by the EC. In the latter paper published recently in kidney international this increase is secondary to NOX activation. This lead to inflammationof the vessel with infliltration of the vessel bymonocyte.
  19. The indoles are important endotheliotoxins. They impaired all the normal function of endothelium.
  20. The mecanismm was mainly the increased expression of ROS. As you can see ion this slide, the only other protein directily increased was the e selectin.
  21. Th indoles clearly play a rol in vivo in the endothelial function as you can see here, if we reduced the amount of circulating is with AST-120 we imporve the endothelial function in human and in mice.
  22. In addition recently indole were show to reduced the regeneration of endothelial cells in a model of the lim ischemia in mouse. As you can see the bllod flow in the limb is impaired in the CKD ou IS injected mice and it is restaured with AST-120. the pathway interestingly is very closed with AhR pathways with a reduction in the expression of HIF1 that reduced the angiogenic functions of progenitor.
  23. Il a été montré que lklotho porotége l’endothélium de la senescence dans plusieurs articles dont vous avez ici avec en particulier une diminution de la senescence quand les cellules endothéliale sont exposé à du klotho soluble. SI la perte du parenchyme rénale diminue la production de klotho, il est cetainement que l’IS coupe la productiond e klotho au niveau rénale par au moins deux phénomènes induction de ROS et modulation de la méthylation du promoteur de klotho. De plus si l’IS entraine une dysfonction endothéliale, klotho est capable de la corriger du moins in vitro.
  24. Que faire pour améliorer cette dysfonction endothéliale? Diminuer les taux de toxines soit sur la production soit en les éliminants et cette article montre que la dialyse élimine des solutés qui inhibe le wound healing par exemple. Les statines avec la limite de l’augmentation des HDL, les inh de ROS comme la NAC, Klotho soluble en perfusion et peut être qu’en plus de l’Epo nous ferons du sklotho à nos patients, enfin mais j’ai un très conflits d’intérêts intellectuel c’est l’inhibition de l’activation d’Ahr.
  25. We are in Vienna and everybody knows the quality of the chocolate in this town. Perhaps, the solution to endothelium dysfnction will be to give chocolate to our patients. A recent paper in cJASN suggest it. Ingestion of cocoa flavanols improve the endothelial function as you can see here, reduced sdiastolic blood pressure and very intersteingly given at the befginning of the HD reduced the endothelial dysfunction induced by the technique. So perhaps we have to do a prescription of chocolate to our patients.
  26. As an introduction to the talk of griet, I like to show you an impressive video from this article published this month. In the brain the repair of small vessels need the help of macrophage. You see here the defect induced by laser shot, the macrophage arrive in green to pull on the endothelial cells to reconnect it. I thing it is a good illustration of the importance of leucocyte to maintain healthy blood vessels. Thank you for your attention.